Noninvasive tissue displacement control and monitoring for neuromodulation

Patent metadata

Field	Value
Publication number	US-11633630-B2
Application number	US-202016750932-A
Country	US
Kind code	B2
Filing date	Jan 23, 2020
Priority date	Jan 23, 2020
Publication date	Apr 25, 2023
Grant date	Apr 25, 2023

Abstract

The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into an internal tissue to cause tissue displacement and identifying that the tissue displacement has occurred. In one embodiment, the presence of tissue displacement is associated with a desired therapeutic or physiological outcome, such as a change in a molecule of interest.

First claim

The invention claimed is:

1. A neuromodulation delivery system, comprising:
an energy application device configured to deliver neuromodulating energy to a region of interest of an internal tissue in a subject; and
a controller configured to:
control application of the neuromodulating energy via the energy application device to the region of interest to deliver a dose of the neuromodulating energy thereto, wherein the energy application device is controlled under control parameters;
receive image data of the region of interest during the application of the neuromodulating energy;
track real-time tissue displacement of the region of interest using the image data;
calculate a rate of change of the real-time tissue displacement during delivery of a portion of the dose;
determine that the rate of change is below a threshold indicative of a tissue displacement plateau;
modify the control parameters to reduce the neuromodulating energy applied via the energy application device responsive to determining that the rate of change is below the threshold; and
apply a remaining portion of the dose using the modified control parameters.

2. The system of claim 1 , wherein the energy application device comprises an ultrasound therapy transducer.

3. The system of claim 2 , wherein the energy application device comprises an imaging transducer configured to acquire the image data.

4. The system of claim 1 , wherein the controller is configured to acquire a baseline image of the region of interest and determine the tissue displacement based on the baseline image and the image data.

5. The system of claim 1 , wherein the controller is configured to provide an indication related to the dose based on the real-time tissue displacement.

6. The system of claim 1 , wherein the control parameters comprise driving voltage, pulse length, and pulse repetition interval.

7. The system of claim 6 , wherein the controller is configured to increase or decrease the pulse length based on a change in concentration of a molecule of interest deviating from a threshold.

8. The system of claim 6 , wherein the controller is configured to increase or decrease the driving voltage based on a change in concentration of a molecule of interest deviating from a threshold.

9. The system of claim 6 , wherein the controller is configured to increase or decrease the pulse repetition interval based on a change in concentration of a molecule of interest deviating from a threshold.

10. The system of claim 1 , wherein the controller is configured to distribute the dose between multiple regions of interest.

11. A neuromodulation delivery system, comprising:
an ultrasound probe configured to deliver neuromodulating energy to a region of interest of an internal tissue in a subject via a therapy transducer and acquire image data of the region of interest via an imaging transducer; and
a controller configured to:
control application of the neuromodulating energy via the therapy transducer of the ultrasound probe to the region of interest to deliver a dose of the neuromodulating energy thereto, wherein the therapy transducer is controlled under control parameters;
receive the image data of the region of interest acquired by the imaging transducer of the ultrasound probe during the application of the neuromodulating energy;
track real-time tissue displacement of the region of interest during the application of the neuromodulating energy based on the image data; and
calculate a rate of change of the real-time tissue displacement during delivery of a portion of the dose;
compare the rate of change to a threshold indicative of a tissue displacement plateau; and
modify the control parameters to reduce the neuromodulating energy applied via the therapy transducer based on the comparing; and
deliver a remaining portion of the dose using the modified control parameters.

12. The system of claim 11 , wherein the control parameters comprise driving voltage, pulse length, and pulse repetition interval.

13. The system of claim 11 , wherein the controller is configured to control application of neuromodulating energy according to the control parameters with a selected driving voltage, pulse length, and pulse repetition interval until a maximum or threshold tissue displacement is identified from the tracked real-time tissue displacement and to modify a driving voltage of the therapy transducer in response to identification of the maximum or threshold tissue displacement.

14. The system of claim 10 , wherein the region of interest comprises a plurality of sites distributed in the internal tissue.

15. A method of delivery of neuromodulating energy, the method comprising: providing a neuromodulation delivery system comprising:
an energy application device configured to deliver neuromodulating energy to a region of interest of an internal tissue in a subject; and
a controller configured to:
control application of the neuromodulating energy via the energy application device to the region of interest to deliver a dose of the neuromodulating energy thereto, wherein the energy application device is controlled under control parameters;
receive image data of the region of interest during the application of the neuromodulating energy;
track real-time tissue displacement of the region of interest using the image data;
calculate a rate of change of the real-time tissue displacement during delivery of a portion of the dose;
determine that the rate of change is below a threshold indicative of a tissue displacement plateau;
modify the control parameters to reduce the neuromodulating energy applied via the energy application device responsive to determining that the rate of change is below the threshold; and
apply a remaining portion of the dose using the modified control parameters

delivering a reference pulse to the region of interest of the subject via an energy application device;
delivering a therapy pulse to the region of interest via the energy application device subsequent to delivering the reference pulse;
delivering a tracking pulse to the region of interest via the energy application device subsequent to delivering the therapy pulse;
identifying a phase change between the reference pulse and the tracking pulse; and
determining a tissue displacement in or near the region of interest based on the phase change.

16. The method of claim 15 , wherein the reference pulse and the tracking pulse are delivered by an imaging transducer and the therapy pulse is delivered by a therapy transducer.

17. The method of claim 15 , wherein the reference pulse and the tracking pulse are delivered according to a first set of control parameters and the therapy pulse is delivered according to a second set of control parameters that are different than the first set of control parameters.

18. The method of claim 15 , wherein the tissue displacement is determined based on an area under the curve of the identified phase change.

19. The method of claim 15 , comprising adjusting control parameters of the therapy pulse based on the determined tissue displacement.

20. The method of claim 15 , comprising determining that the tissue displacement is above a selected threshold and selecting a new region of interest in the subject.

21. The method of claim 15 , determining that the tissue displacement is associated with a change in a concentration of a molecule of interest.

22. A method of delivery of neuromodulating energy, the method comprising:
providing

Assignees

• Gen Electric

Inventors

• Ashe Jeffrey Michael
• Puleo Christopher Michael
• Cotero Victoria Eugenia
• Fan Ying
• Wallace Kirk Dennis
• Graf John Frederick

Classifications

• A61N7/00 Primary

  Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092}) · CPC title

• A61B2034/2065

  Tracking using image or pattern recognition · CPC title

• A61B8/4245

  involving determining the position of the probe, e.g. with respect to an external reference frame or to the patient · CPC title

• A61B2090/378

  using ultrasound · CPC title

• A61B8/5223

  for extracting a diagnostic or physiological parameter from medical diagnostic data (for algorithms to analyse biomedical images G06T7/0012) · CPC title